Open access
Sep 2026
Identification of a Conserved Temporal Molecular Response Signature to CDK4/6 Inhibition Through Multi-Omics Integration Across Cancer Cell Lines
A comprehensive cross-omics approach was applied to identify a conserved molecular response to CDK4/6 inhibition that warrants future experimental and clinical validation and a panel of highly conserved candidate biomarkers warrants future experimental and clinical validation.
Anna C. Hogger, Ting Hong, K. Mantwill et al.
· International Journal of Mol... · 0 citations